Chenjie Xu
Overview
Explore the profile of Chenjie Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
3620
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Li D, Lin J, Zhou L, Yang W, Yin X, et al.
Cardiovasc Diabetol
. 2025 Mar;
24(1):120.
PMID: 40087642
Emerging evidence reveals a complex association between type 2 diabetes (T2D) and coronary heart disease (CHD), which share common risk factors and biological pathways. This study aims to identify the...
2.
Jiang Y, Zhang Q, Hu X, Liang T, Sun A, Xu C, et al.
ACS Sens
. 2025 Mar;
PMID: 40052415
Understanding dynamic changes within cellular microenvironments is crucial for elucidating biological processes and developing targeted therapies. Here, we present a rapid and straightforward strategy for profiling tumor microenvironments via fluorogenic...
3.
Ren L, Wang B, Miao D, Xiang P, Zeng Z, Li Z, et al.
Adv Mater
. 2025 Feb;
:e2417704.
PMID: 39962825
Strategically targeting lymph nodes (LNs) to orchestrate the initiation and regulation of adaptive immune responses is one of the most pressing challenges in the context of vaccination. Herein, a series...
4.
Ji J, Zhou J, Li X, Zhang Y, Gu L, Wang Y, et al.
Acta Biomater
. 2025 Feb;
195:436-450.
PMID: 39933641
Bioactive nanomaterials have been extensively utilized in medical applications. There are, however, very few reports on clinical applications of methylated β-cyclodextrin-derived supramolecular bioactive nanoagents, particularly in relation to the chemical...
5.
Wang R, Yue C, Cong F, Lou Y, Liu Y, Xu C, et al.
Int J Biol Macromol
. 2024 Dec;
286():138501.
PMID: 39647722
Impaired spinal GABAergic inhibitory neuronal system is one popular target for developing new drugs or procedures for treatment of neuropathic pain, but effective and transferable methods are still lacking. We...
6.
Duan T, Cao Z, Wang X, Min J, Sun T, Luo H, et al.
Br J Psychiatry
. 2024 Dec;
:1-8.
PMID: 39629617
Background: Evidence is largely limited regarding the extent to which abnormal behavioural profiles, including physical inactivity, sedentary behaviour and inadequate sleep duration, impact long-term health conditions in individuals with pre-existing...
7.
Ghosh S, Zheng M, He J, Wu Y, Zhang Y, Wang W, et al.
Biomaterials
. 2024 Nov;
315:122973.
PMID: 39613707
No abstract available.
8.
Qu J, Xie K, Chen S, He X, Wang Y, Chamberlin M, et al.
Sci Adv
. 2024 Nov;
10(47):eadq9207.
PMID: 39576849
Closed-loop strategies offer advanced therapeutic potential through intelligent disease management. Here, we develop a hydrogel-based, single-component, organic electronic device for closed-loop neurotherapy. Fabricated out of conductive hydrogels, the device consists...
9.
Cao Z, Min J, Chen H, Hou Y, Yang H, Si K, et al.
Nat Commun
. 2024 Nov;
15(1):9972.
PMID: 39557822
No abstract available.
10.
Ghosh S, Zheng M, He J, Wu Y, Zhang Y, Wang W, et al.
Biomaterials
. 2024 Oct;
314:122908.
PMID: 39454504
Fungal infections affect over 13 million people worldwide and are responsible for 1.5 million deaths annually. Some deep cutaneous fungal infections may extend the dermal barriers to cause systemic infection,...